Saint Louis University (SLU)
We have expertise in drug discovery, primarily in the hit-to-lead and lead optimization space. My expertise is in medicinal chemistry and leadership of multi-disciplinary drug discovery projects. We are currently focused on infectious diseases, including antiparasitics, antibacterials, antifungals and antivirals, but have broader interests that include rare and orphan diseases. We also collaborate with experts in a diverse array of research topics, particularly in helping to translate basic science into potential tool compounds or even clinical candidates.